Holen Sie sich die Stockscreener-App
0.043
9,900%
0.0425
Handel nachbörslich:
.04
-0.003
-6.98%
Vaxxinity Inc Aktie (VAXX) Neueste Nachrichten
Dallas District Court Split in High-Stakes Stock Dispute - Inforney News
Local Man Arrested on Multiple Charges, Including Drug Delivery and Bribery - Inforney News
Top 6 Healthcare Stock Picks in 2025 - timothysykes.com
Hypercholesterolemia Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com
Hypercholesterolemia Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight - Menafn.com
Head to Head Contrast: ANI Pharmaceuticals (NASDAQ:ANIP) vs. Vaxxinity (NASDAQ:VAXX) - Defense World
Forney ISD Issues RFP for Security Guard Services Purchasing Contract Starting July 1 2025 - Inforney News
Crime Stoppers Most Wanted- Jose Raudel Muro-Ortega - Inforney News
Forney Hospital Project Set to Transform City Landscape - Inforney News
Vaccinex plans Nasdaq exit as Alzheimer market pressure grows - Pharmaceutical Technology
New Costco in Forney to Feature $3.5M Fuel Station - Inforney News
BJ's Coming to Forney with $10 Million Dollar Build at Hwy 80 & Gateway - Inforney News
Starbucks in Kroger Set for Remodel This Summer - Inforney News
Burlington to Open a New 22,000 Sq Ft Store at Village at Gateway, Expected to Welcome Shoppers by Early 2026 - Inforney News
Forney Costco Construction Updates: Breaking Ground In April, Won't Open Before TXDOT Bridge Completes - Inforney News
Governors Small Business Summit KaufmanA Sold Out Event - Inforney News
Texas Board Of Education Approves Optional Bible Curriculum In Public Schools - Inforney News
Kaufman's Community Economic Development Award - Inforney News
How a new kind of vaccine could lead to the eradication of Alzheimer's and dementia - New Scientist
Vaxxinity - The Pharma Letter
Study: Therapeutic Parkinson's vaccine safely inhibits alpha-synuclein clumps - Parkinson's News Today
Parkinson's Prevention May Include Tetanus Vaccination - Vax-Before-Travel
Vaxxinity’s Immunotherapy Meets Phase I Goals in Parkinson’s Patients - Inside Precision Medicine
A Potential Parkinson’s Treatment Has Promising Results - Time Magazine
Kaufman County and TXDOT Propose New Outer LoopPublic Input Session - Inforney News
Vaxxinity leaders detail retreat from 'abusive relationship' after 3 years on public market - Fierce Biotech
Terrell Breaks Ground On Northspur Development - Inforney News
Vaxxinity, Inc. (VAXX) Perplexes All, Surges 44% Amidst Delisting Decision - 富途牛牛
What's Driving These Stocks Higher In After-hours? - RTTNews
Why Is Vaxxinity (VAXX) Stock Down 58% Today? - TradingView
Vaxxinity to voluntarily delist from Nasdaq - Investing.com
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting - GlobeNewswire
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates - Yahoo Finance
Vaxxinity Inc Motivates Team with Option Repricing Initiative - TipRanks
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial - ScienceAlert
AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine - Pharmaceutical Technology
Vaxxinity reports breakthrough in Parkinson's treatment By Investing.com - Investing.com UK
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published - GlobeNewswire
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 - GlobeNewswire
Vaxxinity, University of Florida join for work on Parkinson’s vaccine - Parkinson's News Today
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida - Yahoo Finance
Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market - cheddar.com
Vaxxinity, University of Central Florida launch collaboration to advance medicines for use in space - Fierce Biotech
Vaccines show promise against common chronic diseases - Gavi, the Vaccine Alliance
Vaxxinity making vaccines to change the world - Labiotech.eu
Researchers return to Alzheimer's vaccines, buoyed by recent drug success - Reuters
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewswire
Mei Mei Hu - The World Economic Forum
Rene Paula - Columbia Law School
Pursuing A "Biologic Revolution" With Vaxxinity's Mei Mei Hu - Bioprocess Online
Area fire departments fighting large grass fire north of Forney - Inforney News
HEB announces expansion with new stores in Rockwall, Melissa, and Prosper - Inforney News
Baird Starts Vaxxinity With Outperform Rating, Price Target is $7 - MarketScreener
Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX) - Yahoo Finance
Vaxxinity to Present at Upcoming Investor Conferences in September - GlobeNewswire
Fast-Tracked Alzheimer’s Vaccine Seems to Work, But Phase 3 Trials Stalled - Being Patient
UB-311 vaccine found safe, slows decline in mild Alzheimer’s: Trial - Alzheimer's News Today
Vaxxinity publishes positive results in Alzheimer’s trial - Longevity.Technology
Innovative Alzheimer's Disease Vaccine Candidate Can Add Value - Vax-Before-Travel
Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimer’s Disease - Yahoo Finance
Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewswire
Vaxxinity Appoints Dr. Peter Powchik as Global Scientific Director - Yahoo Finance
Vaxxinity Appoints Peter Powchik, M.D., to EVP, Global Scientific Director - citybiz
Parkinson’s vaccine targets toxic alpha-synuclein in Phase 1 trial - Parkinson's News Today
Vaxxinity Demonstrates Target Engagement of Toxic Alpha-Synuclein in Parkinson’s Patients - GlobeNewswire
Michael J. Fox Foundation Funds Parkinson’s Disease Vaccine Candidate - Vax-Before-Travel
Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson's Disease - southfloridahospitalnews.com
Vaxxinity reports positive Parkinson’s vaccine trial results - Longevity.Technology
Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson’s Disease - Yahoo Finance
Van Zandt County Sheriff’s Office mourning loss of Sgt. Jeremy McCoy - Inforney News
How to contact the Daily Bulletin - FinancialContent
Weekly Biotech Pulse: Vaxxinity results, Biogen's FDA review, and more | Pro Recap - Investing.com India
VXX-301, a tau vaccine with optimized properties - BioWorld MedTech
Vaxxinity to Present at World Vaccine Congress, American - GlobeNewswire
0.88%
0.76%
Kapitalisierung:
|
Volumen (24h):